last day for compounded semaglutide The End of Semaglutide: Why the FDA's Decision Matters Patients and Pharmacies - Seattle Plastic Surgery Compounded Semaglutide for Women |

And the agency has warned about companies illegally selling unapproved products containing semaglutide, tirzepatide or retatrutide falsely labeled "for research purposes" or "not for human consumption." As of May 31, 2026, the FDA had received 990 adverse event reports associated with compounded semaglutide and more than 730 associated with compounded tirzepatide

As people get older, free radicals occur more often

Noticing a few extra hairs in the plughole

I'm just going back to the interesting work because the malate being the short chain fatty acid and Mark Shigenaga showing, this is all in animal research, by the way